196 related articles for article (PubMed ID: 10571803)
1. Sharing cross-reactive groups of MHC class I improves long-term graft survival.
Sijpkens YW; Doxiadis II; De Fijter JW; Mallat MJ; van Es LA; De Lange P; Zwinderman AH; Westendorp RG; van Kemenade FJ; Bruijn JA; Claas FH; Paul LC
Kidney Int; 1999 Nov; 56(5):1920-7. PubMed ID: 10571803
[TBL] [Abstract][Full Text] [Related]
2. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
3. Early versus late acute rejection episodes in renal transplantation.
Sijpkens YW; Doxiadis II; Mallat MJ; de Fijter JW; Bruijn JA; Claas FH; Paul LC
Transplantation; 2003 Jan; 75(2):204-8. PubMed ID: 12548124
[TBL] [Abstract][Full Text] [Related]
4. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
Stobbe I; van der Meer-Prins EM; de Lange P; Oudshoorn M; De Meester J; Doxiadis II; Claas FH
Transplantation; 2000 Jul; 70(1):157-61. PubMed ID: 10919594
[TBL] [Abstract][Full Text] [Related]
6. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
[TBL] [Abstract][Full Text] [Related]
7. Effect of HLA matching on renal transplant survival.
Zhou YC; Cecka JM
Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
[TBL] [Abstract][Full Text] [Related]
8. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
9. No impact of cross-reactive group human leucocyte antigen class I matching on long-term kidney graft survival.
Egfjord M; Jakobsen BK; Ladefoged J
Scand J Immunol; 2003 Apr; 57(4):362-5. PubMed ID: 12662299
[TBL] [Abstract][Full Text] [Related]
10. Delayed graft function influences renal function, but not survival.
Boom H; Mallat MJ; de Fijter JW; Zwinderman AH; Paul LC
Kidney Int; 2000 Aug; 58(2):859-66. PubMed ID: 10916111
[TBL] [Abstract][Full Text] [Related]
11. Kidney transplantation, the Halifax experience.
Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
[TBL] [Abstract][Full Text] [Related]
12. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
Opelz G; Döhler B; Middleton D; Süsal C;
Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against MICA antigens and kidney-transplant rejection.
Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
[TBL] [Abstract][Full Text] [Related]
14. Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches.
Sawyer RG; Pelletier SJ; Spencer CE; Pruett TL; Isaacs RB
Liver Transpl; 2000 Mar; 6(2):229-36. PubMed ID: 10719025
[TBL] [Abstract][Full Text] [Related]
15. A multi-factor analysis of kidney regraft outcomes.
Gjertson DW
Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
[TBL] [Abstract][Full Text] [Related]
16. Association of HLA class I antigen matching and early graft outcome in living donor kidney transplantation.
Iqbal MM; Hossain RM; Rashid HU; Rahman MH; Datta M; Hassan MS
Transplant Proc; 2006 Sep; 38(7):2012-3. PubMed ID: 16979982
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
Freitas MC
Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
[TBL] [Abstract][Full Text] [Related]
18. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis.
Siddiqi N; McBride MA; Hariharan S
Kidney Int; 2004 May; 65(5):1906-13. PubMed ID: 15086934
[TBL] [Abstract][Full Text] [Related]
19. Long-term impact of human leukocyte antigen mismatches combined with expanded criteria donor on allograft outcomes in deceased donor kidney transplantation.
Shin S; Kim YH; Choi BH; Choi JY; Jung JH; Cho HK; Han DJ
Clin Transplant; 2015 Jan; 29(1):44-51. PubMed ID: 25382387
[TBL] [Abstract][Full Text] [Related]
20. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
